comparing continuous and fixed duration therapy in cll
Published 1 year ago • 1K plays • Length 4:05Download video MP4
Download video MP3
Similar videos
-
1:13
factors to consider when selecting between continuous and fixed-duration therapy in cll
-
2:41
fixed-duration vs continuous therapy in cll
-
2:08
choosing between continuous versus fixed-duration therapy in cll
-
1:56
choosing between continuous and time-limited therapy in patients with high-risk cll
-
12:46
fixed duration treatment strategies in cll
-
1:34
time-limited vs continuous therapy in cll treatment
-
1:56
the future of fixed-duration therapy in cll
-
3:13
selection for time-limited & continuous therapy in cll
-
2:56
continuous btki therapy in cll: are time-limited combination therapies more beneficial?
-
1:17
optimizing initial therapy in cll: time-limited, all-oral approaches
-
0:49
considering patient preference when selecting between continuous and time-limited therapy in cll
-
12:15
challenges of selecting frontline therapy in cll
-
5:03
understanding patient perspectives in cll treatment
-
2:22
improve study: mrd assessment as an endpoint to define treatment length and intensity in cll
-
1:22
shortening the duration of treatment with fixed-duration or mrd-adapted regimens in cll
-
1:58
comparing the safety & efficacy of reversible and irreversible btk inhibitors in cll
-
1:11
integrating mrd data into treatment decisions in cll
-
0:58
improving the long-term safety of cll treatment
-
7:55
clinical trials of fixed duration treatments & novel targets in cll